Writing for Business of Cannabis, Scott Mazza, co-founder of Vitality CBD, argues that the federal spending bill provision capping finished hemp products at 0.4mg total THC per container misidentifies the problem: targeting compliant producers with USDA organic certification and years of third-party testing behind them rather than the bad actors mislabeling potency or skipping independent testing entirely. Mazza draws on Vitality CBD’s full-spectrum formulations to make the case that the proposed threshold would also eliminate science-backed products: Farm Bill 2018 research now confirms that full-spectrum extraction’s entourage effect delivers stronger therapeutic outcomes than CBD isolate, making the isolate carve-out lawmakers treat as a concession a genuine step backward. He proposes a three-part alternative — FDA oversight through the HEMP Act to remove dangerous products, a federal quality seal rewarding organic certification and transparent testing, and dosage-based rules that distinguish wellness applications from high-dose intoxicants, arguing that a sound regulatory framework for hemp must be built around the producers who have already proven they can meet the highest standards, as published in Business of Cannabis.